Study of Estrogen Receptor and Progesterone Receptor Expression in Breast Ductal Carcinoma In Situ by Immunohistochemical Staining in ER/PgR-Negative Invasive Breast Cancer

Background. To our knowledge, the hormone receptor status of noncontiguous ductal carcinoma in situ (DCIS) occurring concurrently in ER/PgR-negative invasive cancer has not been studied. The current study was undertaken to investigate the ER/PgR receptor status of DCIS of the breast in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Dobrescu, Andrei, Chang, Monique, Kirtani, Vatsala, Turi, George K., Hennawy, Randa, Hindenburg, Alexander A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scholarly Research Network 2011
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3200125/
https://www.ncbi.nlm.nih.gov/pubmed/22091428
http://dx.doi.org/10.5402/2011/673790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3200125/
https://www.ncbi.nlm.nih.gov/pubmed/22091428
http://dx.doi.org/10.5402/2011/673790

Ejemplares similares